Viewing Study NCT02809560


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2026-03-15 @ 4:40 AM
Study NCT ID: NCT02809560
Status: COMPLETED
Last Update Posted: 2016-06-22
First Post: 2016-05-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Detection of Cav1 Calcium Channels in Inflammatory Cells of Asthmatic Children
Sponsor: University Hospital, Toulouse
Organization:

Study Overview

Official Title: Detection of Cav1 Calcium Channels in Inflammatory Cells of Asthmatic Children
Status: COMPLETED
Status Verified Date: 2016-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CAVASTHME
Brief Summary: Asthma affects about 10% of children and 6% of adults in industrialized countries. Lymphocytes (L) Th2, a T cell population (LT) producing interleukin (IL) -4, 5 and 13 are broadly involved in this pathology in experimental models and in humans. Many studies show that the signaling pathways activated by the commitment of T receiver differ depending LT. The identification of specific signaling pathways links to Th2 offer new therapeutic approaches. Precedent study showed that mouse Th2 selectively expressed related to calcium channels sensitive channels Cav1 voltage, normally found in excitable cells where they are defined as receivers dihydropyridine (DHP).

The goal of the present study is to show the presence of Cav1 channels in inflammatory cells in allergic asthmatics and show overexpression of these channels in the peripheral blood mononuclear cells from asthmatic subjects before and / or after stimulation with the TCR in comparison with controls.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: